Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Biopharmaceutical companies are all too familiar with transparency requirements in regulations governing drug research and marketing. Government agencies and consumer groups are making product price data public to curb inappropriate drug use and reduce national healthcare spending. Manufacturers face a proliferation of state and federal requirements for disclosing payments to researchers and medical professionals, and stiff penalties for failure to comply.


Today in Biotechnology...keeping you current

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

Successful purchase of trait platform with extensive product pipeline
BayNews International, 11/06/09

Cell Therapeutics, Inc.s (CTI) Presentation at BIO Investor Forum to be Webcast
Cell Therapeutics, 11/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address